Trial Profile
Phase II trial of BAL 30072 in patients with Gram-negative infections.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 27 Oct 2011
Price :
$35
*
At a glance
- Drugs BAL 30072 (Primary)
- Indications Gram-negative infections
- Focus Therapeutic Use
- 27 Oct 2011 New trial record